Solara Active Pharma Sciences’ consolidated net loss narrows to Rs 13 crore in Q1

22 Jul 2024 Evaluate

Solara Active Pharma Sciences has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported net loss at Rs 12.32 crore for the quarter ended June 30, 2024 as compared to net loss of Rs 19.88 crore for the same quarter in the previous year. However, total income of the company increased by 2.96% at Rs 364.87 crore for Q1FY25 as compared to Rs 354.38 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net loss at Rs 13.46 crore for Q1FY25 as compared to net loss of Rs 19.11 crore for the same quarter in the previous year. However, total income of the company increased by 2.74% at Rs 364.05 crore for Q1FY25 as compared to Rs 354.35 crore for the corresponding quarter previous year.

Solara Active Pharma Share Price

686.95 -33.60 (-4.66%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.